Clinical Trials Browser

Interventional × ixabepilone × Thoracic × Clear all

NCT00741988 2021-12-15

Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer

Phase 2 Completed

82 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT00723957 2020-10-28

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

Phase 2 Completed

260 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung

NCT00832117 2020-10-28

Phase I Combination Ixabepilone + Cisplatin

Phase 1 Completed

30 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Phase 1 Terminated

31 enrolled 12 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT00683904 2016-03-10

Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer

Phase 1 Completed

12 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung

NCT01057212 2015-09-07

Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Phase 2 Terminated

Non-squamous Non-small Cell Lung Cancer

NCT00998101 2012-03-06

Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms